Behavioral Pharmacology of the Cholinergic System

The molecular genetics of the cholinergic system including both muscarinic and nicotinic acetylcholine receptors, cholinesterases, acetylcholine synthesis and release have provided significant insights into potential targeting for pharmacological intervention. Cholinergic drugs are being used or evaluated for the treatment of diseases. Thus, this volume aims to broaden our understanding of the current state of cholinergic mechanisms to enable implementation of novel approaches for the development of more effective treatments.

Maximises readers insight into the translational perspective on targeting nicotinic and muscarinic acetylcholine receptors

Provides an insight into the diverse array of disease states affected by dysfunction of cholinergic systems

Contains a collection of multidisciplinary chapters authored by leading experts who have made significant contributions in the field